MedTrace Logo

A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle

NCT05304390 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2024-12-02

No results posted yet for this study

Summary

This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receiving preventive care, and constantly facing healthcare discrimination. Members of the LGBTQ community have historically smoked at higher rates than the general population and thus could benefit greatly from targeted efforts to improve lung cancer screening and smoking cessation implementation.

Conditions

  • Lung Carcinoma

Interventions

BEHAVIORAL

Patient Navigation

Receive patient navigation intervention

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Smoking Cessation Intervention

Receive an intervention for smoking cessation

PROCEDURE

Carbon Monoxide Measurement

Undergo carbon monoxide measurement

Sponsors & Collaborators

  • LUNGevity Foundation

    collaborator OTHER

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Matthew Triplette · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-06
Primary Completion
2024-10-28
Completion
2024-10-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05304390 on ClinicalTrials.gov